BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

36 related articles for article (PubMed ID: 31414747)

  • 1. Investigating the Current Harmonization Status of Tumor Markers Using Global External Quality Assessment Programs: A Feasibility Study.
    van Rossum HH; Holdenrieder S; Ballieux BEPB; Badrick TC; Yun YM; Zhang C; Patel D; Thelen M; Song J; Wojtalewicz N; Unsworth N; Vesper HW; Cui W; Ramanathan LV; Sturgeon C; Meng QH
    Clin Chem; 2024 Apr; 70(4):669-679. PubMed ID: 38385453
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Machine learning-based delta check method for detecting misidentification errors in tumor marker tests.
    Seok HS; Choi Y; Yu S; Shin KH; Kim S; Shin H
    Clin Chem Lab Med; 2024 Jun; 62(7):1421-1432. PubMed ID: 38095534
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vanadium-doped metal-organic framework@Znln
    Wang X; Tang D; Wan X; Wang H; Tang D
    Talanta; 2024 Aug; 275():126110. PubMed ID: 38631264
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor markers in clinical practice: a review focusing on common solid cancers.
    Duffy MJ
    Med Princ Pract; 2013; 22(1):4-11. PubMed ID: 22584792
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Electrochemical immunosensing of tumor markers.
    Palakollu VN; Veera Manohara Reddy Y; Shekh MI; Vattikuti SVP; Shim J; Karpoormath R
    Clin Chim Acta; 2024 Apr; 557():117882. PubMed ID: 38521164
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of Tumor Markers in Renal Transplant Recipients.
    Fukae S; Yamanaka K; Yonemoto S; Yoshida T; Nakagawa M; Fujii N; Kishikawa H
    Cancer Diagn Progn; 2024; 4(3):270-275. PubMed ID: 38707724
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A highly sensitive ratiometric fluorescence immunoassay based on bioorthogonal nanozymes.
    Liu X; Wang N; Hou Y; Dong H; Liang W; Li X; Yuan Y
    Chem Commun (Camb); 2024 Apr; 60(29):3978-3981. PubMed ID: 38502001
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of Analytical Performances of Magnetic Force-Assisted Electrochemical Sandwich Immunoassay for the Quantification of Carcinoembryonic Antigen.
    Hwang BY; Kim E; Kim SH; Hwang H
    Front Bioeng Biotechnol; 2021; 9():798079. PubMed ID: 35071206
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of the clinical performance of a magnetic force-assisted electrochemical immunoassay for the detection of SARS-CoV-2 antigens.
    Jo SJ; Shin SH; Kim J; Lee S; Lee J
    PLoS One; 2021; 16(10):e0258394. PubMed ID: 34618868
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunosensing procedures for carcinoembryonic antigen using graphene and nanocomposites.
    Luong JHT; Vashist SK
    Biosens Bioelectron; 2017 Mar; 89(Pt 1):293-304. PubMed ID: 26620098
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nanotechnology-based approaches for effective detection of tumor markers: A comprehensive state-of-the-art review.
    Laraib U; Sargazi S; Rahdar A; Khatami M; Pandey S
    Int J Biol Macromol; 2022 Jan; 195():356-383. PubMed ID: 34920057
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of MARK BTM for Quantitative Measurement of Three Tumor Markers: Prostate Specific Antigen, Alpha Fetoprotein, and Carcinoembryonic Antigen.
    Hwang H; Kim J; Choi J; Kim KH; Han HS
    Clin Lab; 2019 Aug; 65(8):. PubMed ID: 31414747
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Measurement of alpha-fetoprotein, carcinoembryonic antigen and prostate-specific antigen in serum and heparinised plasma by enzyme immunoassay on the fully automated serono SR1 analyzer.
    Cattini R; Cooksey M; Robinson D; Brett G; Bacarese-Hamilton T; Jolley N
    Eur J Clin Chem Clin Biochem; 1993 Aug; 31(8):517-24. PubMed ID: 7692986
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of the UniCel™ DxI 800 immunoassay analyzer in measuring five tumor markers.
    Park Y; Park Y; Park J; Kim HS
    Yonsei Med J; 2012 May; 53(3):557-64. PubMed ID: 22477000
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Method comparison for determination of the tumor markers AFP, CEA, PSA and free PSA between Immulite 2000 XPI and Dimension Vista 1500.
    Zur B; Holdenrieder S; Walgenbach-Brünagel G; Albers E; Stoffel-Wagner B
    Clin Lab; 2012; 58(1-2):97-105. PubMed ID: 22372351
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.